Mycobacterial infection after COVID-19 pneumonia
- 2023, Volume 26 - Number 3
- Published: September 29, 2023
Mycobacterial infection after COVID-19 pneumonia
Mateo Hevia-Menéndez 1, Adrián Martínez-Vergara 1, Rosa M. Girón 2
1 Servicio de Neumología, Hospital Universitario de La Princesa, Madrid, España; 2 Servicio de Neumología, Hospital Universitario de la Princesa, Madrid, España
Mateo Hevia-Menéndez, Adrián Martínez-Vergara, Rosa M. Girón
La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.
*Correspondence: Adrián Martínez-Vergara, Email not available
Summary
A 69-year-old man with a history of hypertrophic cardiomyopathy and major depressive disorder was admitted to the Emergency Department with fever, weakness, and shortness of breath. He was diagnosed with acute respiratory distress syndrome due to COVID-19 and received oxygen and steroids during a one-month hospital stay. After discharge, he continued steroids and home oxygen therapy for nearly two years. CT scans revealed bronchiectasis and ground glass opacities related to COVID-19. He developed pulmonary nodules and M. intracellulare infection, which were treated with rifampicin, ethambutol, and azithromycin. After six months of treatment, the patient showed clinical and radiological improvement.
Keywords: COVID19. NTM. Bronchiectasis. Steroids. Immunosuppression. Pulmonary nodules.
